GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Probi AB (OSTO:PROB) » Definitions » 3-Year EBITDA Growth Rate

Probi AB (OSTO:PROB) 3-Year EBITDA Growth Rate : -16.00% (As of Mar. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Probi AB 3-Year EBITDA Growth Rate?

Probi AB's EBITDA per Share for the three months ended in Mar. 2024 was kr2.31.

During the past 12 months, Probi AB's average EBITDA Per Share Growth Rate was -37.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -16.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -6.80% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 14.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Probi AB was 117.80% per year. The lowest was -31.10% per year. And the median was 8.80% per year.


Competitive Comparison of Probi AB's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Probi AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Probi AB's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Probi AB's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Probi AB's 3-Year EBITDA Growth Rate falls into.



Probi AB 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Probi AB  (OSTO:PROB) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Probi AB 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Probi AB's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Probi AB (OSTO:PROB) Business Description

Traded in Other Exchanges
Address
Ideongatan 1 A, Lund, SWE, SE-223 70
Probi AB is engaged in probiotic research and development, manufacturing and sales of effective and well-documented probiotics. The company's research relates to living microorganisms with scientific health benefits. The main fields of research are gut health, immune system and nutrient absorption, iron absorption, bone health and stress and recovery. It operates in Consumer Healthcare (CHC) and Functional Food (FF). The company operates in United States, Americas, excluding the United States , Sweden, EMEA, excluding Sweden, and APAC. The company's business is divided into three operating segments. These segments are based on a geographical division and consist of the regions Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia and the Pacific).

Probi AB (OSTO:PROB) Headlines

No Headlines